Despite great advances in treatments and technology, cancer continues to be the second leading cause of death—worldwide. This makes the market for next generation cancer diagnostics one that is ripe with significant growth potential. A key driving force for industry growth is liquid biopsy-based cancer diagnostics.

Artificial intelligence is an application most everyone is familiar with. Yet, the concept of what AI can do is continually evolving. New systems that are in the process of being developed are opening doors in fields not initially associated to ‘smart robots’ and similar images AI conjures up.

The modernization of technology has led to rapid advances in the printing domain. From paper printing using inkjet and laser technologies, there was the development of 3D printing by Charles Hull.

Discovered in 2006, and awarded the Nobel Prize in 2012, induced pluripotent stem cells (iPSCs) have been waiting in the wings of the theater of drug development. The global iPSC market will see steady growth over the next few years, growing 9.2% annually to reach $3.8 billion by 2024.

Traditional Methods of Alzheimer Disease Diagnosis
Diagnosing Alzheimer Disease (AD) typically involves the use of a combination of neuropsychological tests and neuroimaging assessments. A widely used cognitive test is the Mini-Mental State Examination (MMSE), which evaluates orientation, attention, memory, language and visual-spatial skills.

Biotechnology research is advancing in many fields. For example, genetic sequencing technology is advancing rapidly, with a heaving focus in cancer diagnostics within the healthcare sector.

As the life sciences field evolves, so do the job opportunities it offers.

Biomarkers are at the core of identifying any disease or biological condition, and the discovery of new biomarkers has enormous commercial potential. While aiding in diagnostics, prognostics and companion diagnostics, biomarkers are becoming essential tools in one critical process: drug development. As a result, the biomarkers market has been rapidly expanding in recent years, according to a recent webinar led by BCC Research analyst Marianna Tcherpakov, PhD.